在S129α-synuclein残留物的单点突变及其对结构,聚合和神经毒性的影响
Esha Pandit1, Lopamudra Das1, Anoy Kumar Das2
1Structural Biology and Bioinformatics Division, Indian Institute of Chemical Biology, Council of Scientific and Industrial Research, Kolkata, India.
Frontiers in chemistry
|June 12, 2023
概括
与帕金森病相关的α-synuclein (aS) 蛋白的突变减少了其聚合和毒性. 突变S129A和S129W突变显示稳定性增加,对神经元细胞的有害影响较小.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 结构生物学 结构生物学
背景情况:
- 帕金森病的病理学涉及到α-synuclein (aS) 的聚合物,这是一个内在失序的蛋白质.
- aS的C端域对其溶解性和稳定性至关重要.
- 研究aS中的突变可以揭示疾病机制的洞察力.
研究的目的:
- 为了检查两个单点突变 (S129A和S129W) 在人类α-synuclein (aS) 的C端域中的结构和聚合特性.
- 为了比较这些突变的聚合动力学和细胞毒性与野生类型aS (wt aS).
主要方法:
- 循环二元化 (CD) 和拉曼光谱分析二次结构.
- 提奥夫拉T测定和原子力显微镜用于研究聚合.
- 使用SH-SY5Y神经元细胞系进行细胞毒性测定.
主要成果:
- 突变S129A和S129W表现出增强的结构稳定性和更大的倾向于阿尔法螺旋形状相比wt aS.
- 突变者的α螺旋倾向导致延长滞后阶段,并降低了富含β片纤维化的β片纤维化的增长率.
- 从wt aS形成的寡合体对神经元细胞有显著更大的毒性 (~40%的存活率) 比来自突变蛋白质的寡合体 (~80%的存活率).
结论:
- 在S129A和S129W突变赋予结构稳定性和阿尔法螺旋倾向aS.
- 这种改变的结构导致较慢的寡合化和纤维化率.
- 突变的聚合减少和结构改变有助于它们对神经元细胞的毒性降低,为帕金森病提供了潜在的治疗见解.
更多相关视频
08:40Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry for the Study of Alpha-Synuclein Structural Dynamics Under Physiological Conditions
Published on: June 23, 2022
3.0K
09:27Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
Published on: January 5, 2016
17.4K
相关概念视频
Mutations
83.8K
Overview
83.8K
Point and Frameshift Mutations
38
Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
38
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
